The anti-inflammatory and analgesic activities of 2Br-Crebanine and Stephanine from Stephania yunnanenses H. S.Lo

Lili Cui, Chaorui Peng, Jun Li, Xin Cheng, Xiao Fan, Jingyu Li, Zixian Yang, Yuancui Zhao, Yunshu MaFrontiers in Pharmacology 2023 · DOI

Abstract

Ethnopharmacological relevance: Crebanine (Cre) and Stephanine (Step) are isoquinoline aporphine-type alkaloids extracted from Stephania yunnanenses H. S. Lo, a plant traditionally used to treat stomach pain and rheumatoid arthritis. While potent, these compounds exhibit significant toxicity. This study investigates 10,11-dibrominecrebanine (2Br-Cre), a bromine-modified derivative designed to reduce toxicity and enhance efficacy. Aim: To evaluate the anti-inflammatory and analgesic effects of 2Br-Cre and Step and explore their biological mechanisms. Methods: Effects were tested using various models: ear/paw edema, pleurisy, hot-plate test, naloxone antagonism, and chronic constriction injury (CCI). Cytokine levels were measured in LPS-induced RAW264.7 cells. Results: Both compounds significantly inhibited inflammation (edema, leukocyte migration, NO, PGE2) and increased pain thresholds via opioid receptor-mediated pathways. 2Br-Cre and Step also reduced BDNF levels in CCI models and suppressed pro-inflammatory cytokines (IL-6, IL-1β, TNF-α). Conclusion: 2Br-Cre retains the therapeutic benefits of Cre with improved safety, making it a promising lead compound for analgesia.

Introduction

Plants of the Stephania genus have long been staples in traditional medicine for treating inflammatory conditions like rheumatoid arthritis and abdominal pain. The primary active components are aporphine alkaloids such as Crebanine and Stephanine. However, their clinical utility is limited by a narrow therapeutic window and high toxicity. To address this, researchers synthesized 2Br-Crebanine (2Br-Cre) by modifying the Crebanine skeleton with bromine atoms, aiming to create a safer pharmaceutical candidate.

Methodology

The study utilized a comprehensive experimental framework involving both animal models (KM mice and SD rats) and cellular assays (RAW264.7 mouse macrophages).

Chemical structure of Crebanine
Chemical structure of Stephanine

Experimental Models

  • Anti-Inflammatory Assays: Xylene-induced ear edema and carrageenan-induced paw edema/pleurisy were used to quantify the reduction in swelling and inflammatory markers such as Nitric Oxide (NO) and Prostaglandin E2 (PGE2).
  • Analgesic Assays: Thermal pain was assessed via the hot-plate test, while chemical pain was measured using the acetic acid writhing test. A Chronic Constriction Injury (CCI) model of the sciatic nerve simulated neuropathic pain.
  • Mechanistic Studies: Naloxone, an opioid antagonist, was administered to determine if the analgesic effects were mediated through the body's opioid receptors.
  • In Vitro Assays: Macrophages were stimulated with lipopolysaccharide (LPS) to observe the compounds' impact on cytokine production (TNF-α, IL-6, IL-1β).

Results and Discussion

Enhanced Safety Profile

A pivotal finding was the significantly reduced toxicity of the modified compound. The LD50 (lethal dose for 50% of the population) of 2Br-Cre was approximately 59.62 mg/kg, nearly six times higher than that of the parent Crebanine (~9.38 mg/kg). This suggests that halogenation is an effective strategy for improving the safety profile of aporphine alkaloids.

Anti-Inflammatory and Analgesic Efficacy

Both 2Br-Cre and Step demonstrated robust anti-inflammatory activity, significantly inhibiting edema and reducing the levels of pro-inflammatory mediators. In pain models, the compounds increased thermal pain thresholds and reduced the frequency of writhing. The fact that Naloxone blocked these effects confirms the involvement of the opioid system, similar to traditional painkillers but potentially with a different side-effect profile.

Neuropathic Pain and Cytokine Regulation

In the CCI model, the compounds mitigated the abnormal rise of Brain-Derived Neurotrophic Factor (BDNF) in the brain and serum, a key player in central sensitization for chronic pain. Furthermore, in vitro results showed a dose-dependent suppression of critical cytokines, reinforcing the compounds' multi-faceted therapeutic potential.

Conclusion

The study successfully demonstrates that structural modification of natural alkaloids can yield compounds with superior safety profiles without sacrificing efficacy. 2Br-Cre emerges as a potent anti-inflammatory and analgesic lead, warranting further investigation into its specific opioid receptor targets and pharmacokinetic properties.

Summary updated

Abstract

<b>Ethnopharmacological relevance:</b> Crebanine (Cre) and Stephanine (Step) are isoquinoline aporphine-type alkaloids that are extracted from <i>Stephania yunnanenses</i> H. S. Lo. Plants of the <i>Stephania</i> genus are often used for treatment of stomach pain, abdominal pain, and rheumatoid arthritis. Both Cre and Step exhibit strong activities but are also associated with a certain level of toxicity, 10,11-dibrominecrebanine (2Br-Cre) is a bromine-modified derivative of Cre that we prepared and tested in order to reduce toxicity and enhance efficacy. <b>Aim of this study:</b> To investigate the anti-inflammatory and analgesic effects of 2Br-Cre and Step based on previous research findings and explore the specific biological mechanisms involved. <b>Materials and methods:</b> The anti-inflammatory and analgesic effects of 2Br-Cre and Step were investigated using a range of experimental models, including xylene-induced ear edema, carrageenan-induced pleurisy, carrageenan-induced paw edema, the hot-plate test, the naloxone antagonism test and the acetic acid writhing test. A model of chronic constriction injury (CCI) of the sciatic nerve was also established to investigate therapeutic effects. A RAW264.7 cell model was established using lipopolysaccharide (LPS) to estimate the effects of these compounds on cytokines levels. <b>Results:</b> 2Br-Cre and step significantly inhibited ear edema, paw edema and presented anti-inflammatory activity in the pleurisy model by inhibiting leukocyte migration and nitric oxide (NO) production, and by reducing the levels of PGE2. 2Br-Cre and Step significantly increased the pain threshold of mice subjected to heat stimulation; the effect was blocked by naloxone, thus suggesting that the analgesic effects of 2Br-Cre and Step were mediated by opioid receptors. 2Br-Cre and Step inhibited the frequency of writhing and prolonged the latency of writhing, and reduced the abnormal increase in the levels of BDNF in the serum and brain, thus alleviating the pain caused by CCI. In addition, 2Br-Cre and Step significantly inhibited the production of several inflammatory cytokines (IL-6, IL-1β and TNF-α) by LPS-induced RAW264.7 macrophages (<i>p</i> < .01). <b>Conclusion:</b> 2Br-Cre and Step exerted remarkable anti-inflammatory and analgesic effects. As a structural modification of Cre, 2Br-Cre retains the anti-inflammatory and analgesic activity of Cre but with better efficacy. Consequently, 2Br-Cre should be investigated further as a lead compound for analgesia.
BibTeX
@inproceedings{cui2023anti,
  author = {Lili Cui and Chaorui Peng and Jun Li and Xin Cheng and Xiao Fan and Jingyu Li and Zixian Yang and Yuancui Zhao and Yunshu Ma},
  title = {{The anti-inflammatory and analgesic activities of 2Br-Crebanine and Stephanine from Stephania yunnanenses H. S.Lo}},
  booktitle = {Frontiers in Pharmacology},
  year = {2023},
  doi = {10.3389/fphar.2022.1092583},
}
Figure